Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Untracked COVID: Nursing home workers have died at twice the rate of hospital workers
By
Alicia Lasek
Apr 09, 2021
Nursing home care providers have the sad distinction of accounting for a large proportion of healthcare workers’ COVID deaths, according to new 2020 data that was not tracked by the U.S. government....
Coronavirus rates drop 96% in nursing homes, but some see first-ever cases in new year
By
Alicia Lasek
Mar 31, 2021
More than 430 nursing homes saw their first-ever COVID cases in early 2021, evidence that continued infection control measures are needed, and despite phenomenal declines in facility rates, says the U.S....
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
COVID cases rise in 15 states; variant fuels outbreak in Kentucky nursing home
By
Alicia Lasek
Mar 22, 2021
The average U.S. case rate is falling, but almost a third of states have seen an increase, and one Kentucky facility’s outbreak shows how new COVID-19 variants and vaccination play a role in continued...
Anticipating B117 surge, experts urge continued focus on elders, deferred 2nd vaccine doses
By
Alicia Lasek
Mar 18, 2021
Infectious disease and vaccine experts have laid out a plan for thwarting yet another uptick in transmission and illness. A new surge is likely by the end of April, they say in a CIDRAP report.
November’s drop in COVID deaths may hint at early nursing home success, experts contend
By
Alicia Lasek
Mar 16, 2021
Between spring pandemic lockdowns and November, mortality rates due to COVID-19 in nursing homes declined significantly — well before a vaccine was approved to treat the disease, according to a new study.
This season’s flu vaccinations linked to lower COVID-19 likelihood, severity
By
Alicia Lasek
Feb 24, 2021
People who received a flu vaccination were 24% less likely to test positive for COVID-19. And those who did contract the disease had a less severe course when compared with people who didn’t get a flu...